Illumina cuts annual profit forecast

9 Meters Biopharma

09/08/2023 21:19

Aug 9 (Reuters) - Illumina Inc  ILMN.O  lowered annual
profit forecast on Wednesday, signaling weak demand for its
sequencing and diagnostic services, sending the life sciences
firm's shares down 7.5% after the bell.
    The San Diego, California-based company expects full-year
adjusted profit per share to be between $0.75 and $0.90,
compared with its prior forecast of $1.25 to $1.50 per share.
    
    

 (Reporting by Pratik Jain in Bengaluru; Editing by Shilpi
Majumdar)
 ((Pratik.Jain@thomsonreuters.com;))